Enhanced lovastatin production by solid state fermentation ofMonascus ruber
- 1 February 2005
- journal article
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 10 (1) , 78-84
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite productionEnzyme and Microbial Technology, 2003
- The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged culturesProcess Biochemistry, 2003
- Use of response surface methodology to optimize culture medium for production of lovastatin by Monascus ruberEnzyme and Microbial Technology, 2002
- Repeated fed-batch process for improving lovastatin productionProcess Biochemistry, 2000
- Pleurotusfungi produce mevinolin, an inhibitor of HMG CoA reductaseFEMS Microbiology Letters, 1993
- Interactions of cell morphology and transport processes in the lovastatin fermentationBioprocess and Biosystems Engineering, 1992
- Biosynthesis of monacolins: Conversion of monacolin J to monacolin K (mevinolin).The Journal of Antibiotics, 1990
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.The Journal of Antibiotics, 1979
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976